Concepts (268)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Cone Photoreceptor Cells | 21 | 2013 | 42 | 4.010 |
Why?
|
| Contrast Sensitivity | 22 | 2013 | 72 | 3.160 |
Why?
|
| Electroretinography | 29 | 2013 | 82 | 2.910 |
Why?
|
| Retinitis Pigmentosa | 21 | 2013 | 37 | 2.330 |
Why?
|
| Visual Pathways | 14 | 2011 | 150 | 2.230 |
Why?
|
| Visual Acuity | 26 | 2011 | 192 | 1.670 |
Why?
|
| Papillomavirus Vaccines | 8 | 2019 | 60 | 1.500 |
Why?
|
| Photic Stimulation | 26 | 2013 | 524 | 1.140 |
Why?
|
| Papillomavirus Infections | 8 | 2019 | 311 | 1.130 |
Why?
|
| Adaptation, Ocular | 7 | 2012 | 37 | 1.100 |
Why?
|
| Vaccination | 4 | 2016 | 326 | 1.090 |
Why?
|
| Light | 8 | 2012 | 289 | 1.010 |
Why?
|
| Bronchiolitis | 1 | 2025 | 9 | 0.910 |
Why?
|
| Retinal Diseases | 5 | 2011 | 80 | 0.900 |
Why?
|
| Bronchodilator Agents | 1 | 2025 | 73 | 0.880 |
Why?
|
| Color Vision | 2 | 2012 | 17 | 0.720 |
Why?
|
| Evoked Potentials, Visual | 6 | 2013 | 76 | 0.690 |
Why?
|
| Sensory Thresholds | 16 | 2013 | 53 | 0.690 |
Why?
|
| Vulvar Neoplasms | 1 | 2021 | 21 | 0.690 |
Why?
|
| Adult | 63 | 2021 | 29587 | 0.680 |
Why?
|
| Alphapapillomavirus | 1 | 2021 | 46 | 0.670 |
Why?
|
| Vision, Ocular | 5 | 2006 | 73 | 0.660 |
Why?
|
| Visual Fields | 15 | 2011 | 97 | 0.620 |
Why?
|
| Cancer Survivors | 1 | 2021 | 108 | 0.600 |
Why?
|
| Retinal Ganglion Cells | 4 | 2013 | 73 | 0.590 |
Why?
|
| Neoplasms, Second Primary | 1 | 2021 | 244 | 0.590 |
Why?
|
| Pattern Recognition, Visual | 5 | 2010 | 159 | 0.580 |
Why?
|
| Automobile Driving | 3 | 2016 | 36 | 0.560 |
Why?
|
| Retinal Degeneration | 6 | 2001 | 30 | 0.560 |
Why?
|
| Male | 65 | 2025 | 47257 | 0.550 |
Why?
|
| Middle Aged | 51 | 2019 | 29532 | 0.540 |
Why?
|
| Psychophysics | 9 | 2011 | 72 | 0.520 |
Why?
|
| Vision Disorders | 6 | 2011 | 72 | 0.500 |
Why?
|
| Vaccination Refusal | 1 | 2016 | 15 | 0.480 |
Why?
|
| Female | 59 | 2025 | 51756 | 0.480 |
Why?
|
| Pediatricians | 1 | 2016 | 25 | 0.480 |
Why?
|
| Communicable Disease Control | 1 | 2016 | 55 | 0.480 |
Why?
|
| Professional-Family Relations | 1 | 2016 | 60 | 0.470 |
Why?
|
| Transportation | 1 | 2016 | 26 | 0.470 |
Why?
|
| Space Perception | 4 | 1999 | 113 | 0.460 |
Why?
|
| Humans | 77 | 2025 | 98362 | 0.450 |
Why?
|
| X Chromosome | 6 | 2002 | 154 | 0.450 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 49 | 0.450 |
Why?
|
| Papillomaviridae | 4 | 2021 | 184 | 0.410 |
Why?
|
| Genetic Linkage | 6 | 2002 | 613 | 0.410 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2019 | 602 | 0.410 |
Why?
|
| Interneurons | 5 | 2012 | 103 | 0.390 |
Why?
|
| Feedback | 3 | 2009 | 132 | 0.390 |
Why?
|
| Parents | 1 | 2016 | 323 | 0.390 |
Why?
|
| Orientation | 3 | 2010 | 109 | 0.390 |
Why?
|
| Paraneoplastic Syndromes | 2 | 2004 | 16 | 0.380 |
Why?
|
| Optic Atrophy | 1 | 2012 | 5 | 0.380 |
Why?
|
| Influenza, Human | 1 | 2016 | 357 | 0.370 |
Why?
|
| Uterine Cervical Neoplasms | 5 | 2019 | 325 | 0.360 |
Why?
|
| Vision Tests | 7 | 2011 | 18 | 0.350 |
Why?
|
| Visual Field Tests | 8 | 2007 | 16 | 0.350 |
Why?
|
| Neoplasms | 2 | 2021 | 3348 | 0.350 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2011 | 6 | 0.340 |
Why?
|
| Astigmatism | 1 | 2011 | 5 | 0.340 |
Why?
|
| Dark Adaptation | 6 | 2013 | 12 | 0.340 |
Why?
|
| Form Perception | 3 | 1997 | 35 | 0.340 |
Why?
|
| Nerve Fibers | 1 | 2011 | 40 | 0.340 |
Why?
|
| Fovea Centralis | 4 | 2005 | 19 | 0.340 |
Why?
|
| Night Blindness | 4 | 2013 | 4 | 0.310 |
Why?
|
| Child | 15 | 2021 | 7745 | 0.300 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2013 | 38 | 0.290 |
Why?
|
| Communication | 1 | 2012 | 456 | 0.280 |
Why?
|
| Physician-Patient Relations | 2 | 2014 | 580 | 0.280 |
Why?
|
| Melanoma | 2 | 2004 | 524 | 0.270 |
Why?
|
| Photoreceptor Cells, Vertebrate | 3 | 2007 | 8 | 0.270 |
Why?
|
| Skin Neoplasms | 2 | 2004 | 638 | 0.260 |
Why?
|
| Adolescent | 20 | 2019 | 10137 | 0.240 |
Why?
|
| Young Adult | 8 | 2019 | 7568 | 0.230 |
Why?
|
| Retinoschisis | 1 | 2005 | 3 | 0.230 |
Why?
|
| Pediatrics | 3 | 2025 | 421 | 0.220 |
Why?
|
| Fourier Analysis | 4 | 2012 | 124 | 0.210 |
Why?
|
| Macular Degeneration | 2 | 2001 | 45 | 0.190 |
Why?
|
| Antiviral Agents | 1 | 2005 | 369 | 0.190 |
Why?
|
| Multimedia | 2 | 2012 | 9 | 0.180 |
Why?
|
| Child, Preschool | 5 | 2025 | 4038 | 0.160 |
Why?
|
| Retina | 4 | 2013 | 221 | 0.160 |
Why?
|
| SEER Program | 1 | 2021 | 247 | 0.160 |
Why?
|
| Case-Control Studies | 6 | 2013 | 2009 | 0.160 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 622 | 0.160 |
Why?
|
| Risk | 1 | 2021 | 660 | 0.150 |
Why?
|
| Incidence | 3 | 2021 | 1787 | 0.150 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2025 | 663 | 0.150 |
Why?
|
| Tomography, Optical Coherence | 3 | 2011 | 130 | 0.150 |
Why?
|
| Trust | 2 | 2019 | 106 | 0.150 |
Why?
|
| Infant | 2 | 2025 | 3358 | 0.140 |
Why?
|
| Health Education | 1 | 2019 | 108 | 0.140 |
Why?
|
| Motion Perception | 1 | 1999 | 104 | 0.140 |
Why?
|
| Skating | 1 | 2017 | 2 | 0.130 |
Why?
|
| Hamstring Muscles | 1 | 2017 | 2 | 0.130 |
Why?
|
| Pyomyositis | 1 | 2017 | 2 | 0.130 |
Why?
|
| Thigh | 1 | 2017 | 42 | 0.130 |
Why?
|
| Lens, Crystalline | 2 | 1998 | 67 | 0.120 |
Why?
|
| Artifacts | 1 | 1998 | 248 | 0.120 |
Why?
|
| Immunization Programs | 2 | 2014 | 28 | 0.120 |
Why?
|
| Physicians' Offices | 1 | 2016 | 4 | 0.120 |
Why?
|
| Scattering, Radiation | 4 | 2005 | 122 | 0.120 |
Why?
|
| Chemotherapy-Induced Febrile Neutropenia | 1 | 2016 | 6 | 0.120 |
Why?
|
| Blood Culture | 1 | 2016 | 13 | 0.120 |
Why?
|
| Point Mutation | 3 | 2011 | 237 | 0.120 |
Why?
|
| Escherichia coli Infections | 1 | 2016 | 38 | 0.120 |
Why?
|
| Refractive Errors | 2 | 2005 | 3 | 0.120 |
Why?
|
| Mutation, Missense | 2 | 2013 | 309 | 0.110 |
Why?
|
| Time Factors | 4 | 2009 | 5576 | 0.110 |
Why?
|
| Vaginal Smears | 2 | 2013 | 71 | 0.110 |
Why?
|
| Communicable Diseases | 1 | 2016 | 74 | 0.110 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 102 | 0.110 |
Why?
|
| Bacteremia | 1 | 2016 | 110 | 0.110 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2014 | 4 | 0.110 |
Why?
|
| School Health Services | 1 | 2014 | 20 | 0.110 |
Why?
|
| United States | 5 | 2016 | 8258 | 0.100 |
Why?
|
| Chicago | 2 | 2016 | 1519 | 0.100 |
Why?
|
| Guideline Adherence | 1 | 2016 | 250 | 0.100 |
Why?
|
| Schools | 1 | 2014 | 95 | 0.100 |
Why?
|
| Lighting | 2 | 2006 | 31 | 0.100 |
Why?
|
| Algorithms | 3 | 2013 | 2003 | 0.100 |
Why?
|
| National Health Programs | 1 | 2013 | 19 | 0.100 |
Why?
|
| Risk Factors | 3 | 2021 | 6271 | 0.100 |
Why?
|
| Attitude of Health Personnel | 2 | 2008 | 686 | 0.100 |
Why?
|
| Escherichia coli | 1 | 2016 | 572 | 0.100 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2013 | 8 | 0.100 |
Why?
|
| Myopia | 1 | 2013 | 10 | 0.100 |
Why?
|
| Proteoglycans | 1 | 2013 | 76 | 0.090 |
Why?
|
| Aged | 13 | 2016 | 21844 | 0.090 |
Why?
|
| Mother-Child Relations | 1 | 2012 | 31 | 0.090 |
Why?
|
| Differential Threshold | 2 | 2003 | 11 | 0.090 |
Why?
|
| Electrodes, Implanted | 1 | 2013 | 192 | 0.090 |
Why?
|
| Physician's Role | 1 | 2014 | 181 | 0.090 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2014 | 152 | 0.090 |
Why?
|
| RNA, Viral | 1 | 2013 | 288 | 0.090 |
Why?
|
| Parenting | 1 | 2012 | 70 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2025 | 11039 | 0.090 |
Why?
|
| Aberrometry | 1 | 2011 | 1 | 0.090 |
Why?
|
| Eyeglasses | 1 | 2011 | 8 | 0.090 |
Why?
|
| Vision Screening | 1 | 1991 | 2 | 0.090 |
Why?
|
| Education, Medical, Continuing | 1 | 2012 | 100 | 0.080 |
Why?
|
| Mothers | 1 | 2012 | 149 | 0.080 |
Why?
|
| GTP Phosphohydrolases | 1 | 2011 | 83 | 0.080 |
Why?
|
| Choroideremia | 2 | 2002 | 2 | 0.080 |
Why?
|
| Mouth Neoplasms | 1 | 2013 | 223 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 419 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 130 | 0.080 |
Why?
|
| Models, Neurological | 1 | 2013 | 411 | 0.080 |
Why?
|
| Retinal Bipolar Cells | 1 | 2009 | 5 | 0.070 |
Why?
|
| Time Perception | 1 | 2009 | 23 | 0.070 |
Why?
|
| Motivation | 1 | 2012 | 344 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2012 | 314 | 0.070 |
Why?
|
| Retinal Rod Photoreceptor Cells | 2 | 2002 | 11 | 0.070 |
Why?
|
| Public Opinion | 1 | 2008 | 55 | 0.070 |
Why?
|
| Mass Screening | 1 | 2013 | 751 | 0.070 |
Why?
|
| Judgment | 1 | 2008 | 69 | 0.060 |
Why?
|
| Eye Proteins | 2 | 1998 | 131 | 0.060 |
Why?
|
| Cataract | 2 | 2005 | 87 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 1116 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 350 | 0.060 |
Why?
|
| Genitalia | 1 | 2005 | 18 | 0.060 |
Why?
|
| Models, Psychological | 1 | 2006 | 166 | 0.060 |
Why?
|
| Pipecolic Acids | 3 | 2010 | 14 | 0.060 |
Why?
|
| Nonlinear Dynamics | 1 | 2005 | 66 | 0.060 |
Why?
|
| Immunization | 1 | 2005 | 154 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2010 | 78 | 0.060 |
Why?
|
| Heterozygote | 2 | 2003 | 392 | 0.050 |
Why?
|
| Geniculate Bodies | 1 | 2005 | 138 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2011 | 1290 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 2574 | 0.050 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2005 | 114 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2004 | 890 | 0.050 |
Why?
|
| Glaucoma | 1 | 2003 | 35 | 0.050 |
Why?
|
| Recurrence | 1 | 2005 | 1264 | 0.040 |
Why?
|
| Reference Values | 2 | 2001 | 608 | 0.040 |
Why?
|
| Mycoses | 1 | 2002 | 46 | 0.040 |
Why?
|
| Kinetics | 1 | 2004 | 1477 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2002 | 83 | 0.040 |
Why?
|
| Psychometrics | 2 | 2007 | 356 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2002 | 184 | 0.040 |
Why?
|
| Aminobutyrates | 2 | 2010 | 11 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2010 | 43 | 0.040 |
Why?
|
| Codon | 1 | 1998 | 116 | 0.030 |
Why?
|
| Saccades | 1 | 1998 | 79 | 0.030 |
Why?
|
| Vision, Monocular | 1 | 1997 | 15 | 0.030 |
Why?
|
| Intermediate Filament Proteins | 1 | 1997 | 35 | 0.030 |
Why?
|
| Phenylalanine | 1 | 1997 | 31 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 667 | 0.030 |
Why?
|
| Serine | 1 | 1997 | 106 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 161 | 0.030 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 2 | 2005 | 15 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 214 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 2792 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1998 | 670 | 0.030 |
Why?
|
| Depth Perception | 1 | 1995 | 18 | 0.030 |
Why?
|
| Optic Nerve Diseases | 1 | 1995 | 16 | 0.030 |
Why?
|
| Perceptual Disorders | 1 | 1995 | 14 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 977 | 0.030 |
Why?
|
| Prognosis | 2 | 2013 | 4126 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 2 | 2013 | 894 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 1997 | 446 | 0.030 |
Why?
|
| Genital Neoplasms, Male | 1 | 2014 | 9 | 0.030 |
Why?
|
| Human papillomavirus 18 | 1 | 2014 | 22 | 0.030 |
Why?
|
| Human papillomavirus 16 | 1 | 2014 | 46 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2014 | 69 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 1997 | 526 | 0.030 |
Why?
|
| Perceptual Masking | 1 | 2013 | 13 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 3032 | 0.020 |
Why?
|
| Pedigree | 3 | 2002 | 987 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2014 | 118 | 0.020 |
Why?
|
| Fundus Oculi | 3 | 1998 | 26 | 0.020 |
Why?
|
| Genital Neoplasms, Female | 1 | 2014 | 118 | 0.020 |
Why?
|
| Rats | 2 | 2009 | 4074 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2007 | 4817 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2013 | 127 | 0.020 |
Why?
|
| Informed Consent | 1 | 2014 | 281 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2014 | 340 | 0.020 |
Why?
|
| Exons | 1 | 2013 | 457 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1991 | 244 | 0.020 |
Why?
|
| Retinal Neurons | 1 | 2010 | 11 | 0.020 |
Why?
|
| Intravitreal Injections | 1 | 2010 | 69 | 0.020 |
Why?
|
| Rabbits | 1 | 2010 | 582 | 0.020 |
Why?
|
| Vitreous Body | 1 | 2009 | 52 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 1529 | 0.020 |
Why?
|
| Injections | 1 | 2009 | 131 | 0.020 |
Why?
|
| Illinois | 1 | 1991 | 524 | 0.020 |
Why?
|
| Sexual Abstinence | 1 | 2008 | 10 | 0.020 |
Why?
|
| Papanicolaou Test | 1 | 2008 | 39 | 0.020 |
Why?
|
| Parental Consent | 1 | 2008 | 36 | 0.020 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2008 | 6 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2007 | 1945 | 0.020 |
Why?
|
| Family Practice | 1 | 2008 | 76 | 0.020 |
Why?
|
| Rats, Long-Evans | 1 | 2008 | 53 | 0.020 |
Why?
|
| Visual Perception | 1 | 2011 | 341 | 0.020 |
Why?
|
| Religion | 1 | 2008 | 101 | 0.020 |
Why?
|
| Health Surveys | 1 | 2008 | 254 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1255 | 0.020 |
Why?
|
| Animals | 3 | 2010 | 28981 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 813 | 0.010 |
Why?
|
| Tonometry, Ocular | 1 | 2003 | 11 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2003 | 2056 | 0.010 |
Why?
|
| Intraocular Pressure | 1 | 2003 | 63 | 0.010 |
Why?
|
| North Carolina | 1 | 2002 | 59 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 2002 | 57 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 2002 | 380 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 1009 | 0.010 |
Why?
|
| Glare | 1 | 1998 | 1 | 0.010 |
Why?
|
| Valine | 1 | 1998 | 48 | 0.010 |
Why?
|
| Glycine | 1 | 1998 | 96 | 0.010 |
Why?
|
| Peripherins | 1 | 1997 | 4 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1997 | 42 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1997 | 25 | 0.010 |
Why?
|
| Half-Life | 1 | 1997 | 89 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1998 | 554 | 0.010 |
Why?
|
| Self Disclosure | 1 | 1997 | 29 | 0.010 |
Why?
|
| Deafness | 1 | 1997 | 50 | 0.010 |
Why?
|
| Family | 1 | 1998 | 329 | 0.010 |
Why?
|
| Photoreceptor Cells | 1 | 1996 | 21 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2002 | 2548 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2002 | 3227 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1996 | 286 | 0.010 |
Why?
|
| Electrooculography | 1 | 1993 | 22 | 0.010 |
Why?
|
| Photography | 1 | 1993 | 43 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 1992 | 108 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1992 | 578 | 0.010 |
Why?
|
| DNA | 1 | 1997 | 1275 | 0.010 |
Why?
|
| Aging | 1 | 1993 | 770 | 0.000 |
Why?
|
| Computer Simulation | 1 | 1992 | 1147 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1996 | 3633 | 0.000 |
Why?
|